Greater Philadelphia sits at the forefront of a dynamic life sciences evolution, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to...
What You'll Learn: How will lower interest rates influence biotech funding, investment flows, and real estate capital allocation in 2025? With a record volume of new lab and GMP supply...
Drive Excellence in Compounding Compliance and Quality Standards The Compounding Pharmacy Compliance Year-End Summit provides cutting-edge insights on GLP-1 regulatory and compliance updates, operational excellence, and proven strategies to drive...
The PBM Contracting Summit brings together industry leaders to tackle rising drug costs head-on – spotlighting bold innovations in contracting, GLP-1 strategy, AI-powered solutions, and federal & state-driven regulatory change....
After an explosive pandemic-era expansion, the Mid-Atlantic life sciences market is undergoing a reset. According to Cushman & Wakefield, availability in Suburban Maryland alone has climbed to a record 20.2%, with 14% vacancy and...
Driven by market dynamics and led by champions of channel strategy, Trade and Channel Strategies celebrates its 20th year as the industry's premier event for trade, channel, market access, account...
What You'll Learn: Which macro policy shifts from NIH indirect caps to ESG financing mandates could reshape New York’s ecosystem in the years ahead? With NYC’s lab vacancy rate being...
In January 2026, the global healthcare industry will once again turn its attention to San Francisco. As a key satellite event ahead of the J.P. Morgan Healthcare Conference, the BIOSeedin Winter...
The 2026 Innovations in Regulatory Science Summit will highlight the latest developments in regulatory science, with panels on artificial intelligence, early endpoints, FDA leaders, and biopharmaceutical company leaders. We will...
Innovation X Health, a thought-leadership platform curated by Decimal.health, will host the Innovation X Health Program during the JPM 2026 Healthcare Conference, bringing together leaders across biotech, pharma, health systems,...
Over the past decade, China's innovative drug pipeline has experienced explosive growth, becoming an integral part of the global pharmaceutical landscape. In 2025, the total value of cross-border licensing for...
The Road Ahead: Pharma, Biotech and Healthcare in a Pivotal Year With fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare....
